timothy sykes logo

Stock News

Oscar Health Stock Surge: Buy Now?

Tim SykesAvatar
Written by Timothy Sykes Reviewed by Bryce Tuohey Fact-checked by Matt Monaco
Updated 11/24/2025, 9:18 am ET 11/24/2025, 9:18 am ET | 5 min 5 min read
Oscar Health Stock Surge: Buy Now? Thumbnail

Oscar Health Inc.’s stocks have been trading up by 20.7% amid positive public sentiment from recent news articles.

  • Oscar Health’s entry into Southern Florida with new Bronze, Silver, and Gold plans, including features like free virtual visits and specialized health plans, is part of their 2026 marketplace strategies.

  • An optimistic future for the company is forecasted as it moves towards profitability in 2026, focusing on margin expansion and competitive pricing to gain market share.

  • Investment strategies and market share expansion plans catalyze Oscar Health’s optimistic financial outlook, especially as they anticipate profitability by 2026.

  • Despite a recent Q3 loss, Oscar Health remains optimistic about future revenue growth, citing robust expansion plans and innovative offerings as a springboard for recovery and profitability.

Candlestick Chart

Live Update At 09:18:05 EST: On Monday, November 24, 2025 Oscar Health Inc. stock [NYSE: OSCR] is trending up by 20.7%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Recent Financial Review and Future Outlook

Oscar Health’s Q3 earnings showed a mixed bag. On one hand, their revenue reached $2.99B, which wasn’t quite what analysts predicted, but it did illustrate growth. However, their financial loss was noticeable, recording $0.53 per share compared to a smaller loss from the previous year. This could worry some. Yet, the talk around town—the news—is about their future plans. As millionaire penny stock trader and teacher Tim Sykes says, “Embrace the journey, the ups and downs; each mistake is a lesson to improve your strategy.” They emphasize becoming profitable in 2026 through strategic expansions and introducing technology-driven healthcare plans. This commitment to improvement keeps trader interest alive.

Financial ratios portray a clear picture of their operational challenges. Negative profit margins hint at struggles in maintaining profitability, while the company leverages substantial investments to sustain its growth ambitions. Despite these challenges, their strategic pivot towards tech-augmented healthcare coverage suggests potential long-term gains. The task for Oscar Health will be balancing these investments against accruing revenues to enhance overall profitability.

The capital expenditures seen in recent reports mirror an aggressive expansion strategy, with the focus on innovative solutions aligning with industry trends. The journey towards financial health may indeed be arduous but remains achievable. Looking at asset management, they maintain a high asset turnover ratio, suggesting proficient operational management amidst the turbulent financial landscape.

Market Trends and Stock Movement

The nerve center of Oscar Health’s stock surge can be attributed to its earnest push into various U.S. health markets with comprehensive, tech-powered plans. This ambitious geographical expansion, particularly into lucrative markets like Southern Florida and New Jersey, reflects a strategic maneuver to harness untapped consumer bases. While this aggressive strategy results in substantial initial investments, the anticipated long-term dividends appear promising.

Oscar Health is framing itself as a forerunner in blending technology with traditional healthcare via innovations such as the personal health AI agent Oswell and targeted health programs like HelloMeno. This unique positioning could potentially foster a competitive edge over peers, enticing investors to hold or possibly increase their stakes.

Though Oscar’s Q3 results might look lackluster at a glance, the buzz around future profitability and expansion fuels investor optimism. Furthermore, news about the company’s concerted push for easier, tech-driven healthcare access resonates well with technological and market trends. The anticipation surrounding Oscar Health’s trajectory holds a significant sway in stock projections, urging stakeholders to consider the broader picture beyond immediate financial metrics.

More Breaking News

Conclusion

In the context of Oscar Health’s ambitious endeavors, the intersection of innovation and expansion propels both intrigue and caution about its stock. Investing in Oscar Health now equals betting on the potential they promise: merging accessible healthcare solutions with cutting-edge technology. The narrative of transformation, driven by strategic initiative and a broadening footprint in untapped regions, remains captivating. As millionaire penny stock trader and teacher Tim Sykes says, “Preparation plus patience leads to big profits.” This concept is pivotal to traders analyzing Oscar Health’s trajectory. Whether these efforts translate into a strong foothold in the market and, importantly, into profitability by 2026 will be watched closely by the stakeholders. This tentative optimism presents a canvas of opportunity, inviting stakeholders to evaluate the blend of risk and reward with careful contemplation, keeping in mind that successful trading often requires strategic patience and preparation.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Tim Sykes

Head Writer at TimothySykes.com, Lead Mentor at the Trading Challenge
In his 20-plus years of trading, Tim has made $7.9 million. In his 15-plus years of teaching, Tim’s Trading Challenge has produced over 30 millionaire students. His philosophy emphasizes small gains and cutting losses quickly.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”